Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taclonex for Localized Mild Breakthrough in Psoriasis Patients on Efalizumab
NCT00608777Phase 4Terminated
- Sponsor
- DermResearch
- Start
- Jan 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of calcipotriol + betamethasone in plaque psoriasis, sponsored by DermResearch. Started Jan 2008; status: terminated.
02
Drugs
calcipotriol + betamethasone
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00608777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00608777.